Insulin Resistance Intervention After Stroke Trial

Trial ID or NCT#



not recruiting iconNOT RECRUITING


The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.

Official Title

Insulin Resistance Intervention After Stroke (IRIS) Trial

Eligibility Criteria

Ages Eligible for Study: Older than 40 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Maarten Lansberg, MD, PhD
Maarten Lansberg, MD, PhD
Stroke and vascular neurologist, General neurologist
Professor of Neurology and, by courtesy, of Neurosurgery
Anna Finley Caulfield, MD
Anna Finley Caulfield, MD
Neurocritical care specialist
Clinical Associate Professor, Neurology & Neurological Sciences
Gregory W. Albers, MD
Gregory W. Albers, MD
Stroke and vascular neurologist
Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery
Chitra Venkatasubramanian, MBBS, MD
Chitra Venkatasubramanian, MBBS, MD
Stroke and vascular neurologist, Neurocritical care specialist
Clinical Professor, Neurology & Neurological Sciences Clinical Professor (By courtesy), Neurosurgery

Contact us to find out if this trial is right for you.


Madelleine Garcia